Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
Cell Death & Disease
Grassi, Ludovica L; Alfonsi, Romina R; Francescangeli, Federica F; Signore, Michele M; De Angelis, Maria Laura ML; Addario, Antonio A; Costantini, Manuela M; Flex, Elisabetta E; Ciolfi, Andrea A; Pizzi, Simone S; Bruselles, Alessandro A; Pallocca, Matteo M; Simone, Giuseppe G; Haoui, Mustapha M; Falchi, Mario M; Milella, Michele M; Sentinelli, Steno S; Di Matteo, Paola P; Stellacci, Emilia E; Gallucci, Michele M; Muto, Giovanni G; Tartaglia, Marco M; De Maria, Ruggero R; Bonci, Désirée D
Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.
Aids Research And Therapy
Silver, Nicholas N; Paynter, Mary M; McAllister, Georgina G; Atchley, Maureen M; Sayir, Christine C; Short, John J; Winner, Dane D; Alouani, David J DJ; Sharkey, Freddie H FH; Bergefall, Kicki K; Templeton, Kate K; Carrington, David D; Quiñones-Mateu, Miguel E ME
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.
Plos One
Cooper, David A DA; Cordery, Damien V DV; Zajdenverg, Roberto R; Ruxrungtham, Kiat K; Arastéh, Keikawus K; Bergmann, Frank F; Neto, José L de Andrade JL; Scherer, Joseph J; Chaves, Ricardo L RL; Robinson, Patrick P; ,